Peter A. Libby

Peter A. Libby

Cardiology

70 Francis Street
Carl J. And Ruth Shapiro Cardiovascular Center
Boston, MA 02115

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 523 publications

Statin Use and Genetically Predicted HMG-CoA Reductase Inhibition in Relation to Clonal Hematopoiesis.

Statin Use and Genetically Predicted HMG-CoA Reductase Inhibition in Relation to Clonal Hematopoiesis.

Journal: medRxiv : the preprint server for health sciences

Published: July 30, 2026

Seeking the Sweet Spot in Targeting Cardiovascular Inflammation.

Seeking the Sweet Spot in Targeting Cardiovascular Inflammation.

Journal: Journal of the American College of Cardiology

Published: June 10, 2026

Targeting Inflammation in Atherosclerotic Cardiovascular Disease: Mechanisms and Emerging Therapies.

Targeting Inflammation in Atherosclerotic Cardiovascular Disease: Mechanisms and Emerging Therapies.

Journal: Immunological reviews

Published: June 05, 2026

Author Correction: The AIM2 inflammasome exacerbates atherosclerosis in clonal haematopoiesis.

Author Correction: The AIM2 inflammasome exacerbates atherosclerosis in clonal haematopoiesis.

Journal: Nature

Published: May 14, 2026

Preemptive cardioprotection with a small molecule in rodents that suppresses genes predictive of heart failure.

Preemptive cardioprotection with a small molecule in rodents that suppresses genes predictive of heart failure.

Journal: Science advances

Published: May 13, 2026

Eugene Braunwald: The Consummate Author and Editor.

Eugene Braunwald: The Consummate Author and Editor.

Journal: Journal of the American College of Cardiology

Published: May 03, 2026

Response to the letter regarding "Lipoprotein(a): A call to acknowledge initial laboratory and clinical practice costs of testing".

Response to the letter regarding "Lipoprotein(a): A call to acknowledge initial laboratory and clinical practice costs of testing".

Journal: Journal of clinical lipidology

Published: May 03, 2026

Effect of Interleukin-6 Receptor Inhibition by Tocilizumab on Platelet Activation and Markers of Thrombus Formation: A Substudy of the ASSAIL-MI Trial.

Effect of Interleukin-6 Receptor Inhibition by Tocilizumab on Platelet Activation and Markers of Thrombus Formation: A Substudy of the ASSAIL-MI Trial.

Journal: Arteriosclerosis, thrombosis, and vascular biology

Published: April 23, 2026

Rethinking triglycerides in the management of ASCVD.

Rethinking triglycerides in the management of ASCVD.

Journal: European journal of preventive cardiology

Published: April 16, 2026

Gamut of Patients Referred to Cardiology for Question of Clonal Hematopoiesis.

Gamut of Patients Referred to Cardiology for Question of Clonal Hematopoiesis.

Journal: Circulation. Genomic and precision medicine

Published: April 07, 2026

A quantitative method to estimate free interleukin-6 among patients treated with the interleukin-6 ligand inhibitor ziltivekimab: comparison to C-reactive protein with implications for the ZEUS, HERMES, and ARTEMIS cardiovascular outcomes trials.

A quantitative method to estimate free interleukin-6 among patients treated with the interleukin-6 ligand inhibitor ziltivekimab: comparison to C-reactive protein with implications for the ZEUS, HERMES, and ARTEMIS cardiovascular outcomes trials.

Journal: Atherosclerosis

Published: March 31, 2026

Clonal haematopoiesis of indeterminate potential in cardiovascular medicine: is it time for selective testing?

Clonal haematopoiesis of indeterminate potential in cardiovascular medicine: is it time for selective testing?

Journal: European heart journal

Published: March 03, 2026

Showing 1-12 of 523

Last Updated: 09/26/2026